Victrex declines after reporting divisional difficulties

Shares in FTSE 250 materials group Victrex moved lower on Tuesday after the group reported a decline in half year revenues in its Invibio Biomaterial Solutions business and warned of the ongoing challenges in some of its end markets.

Shares in FTSE 250 materials group Victrex moved lower on Tuesday after the group reported a decline in half year revenues in its Invibio Biomaterial Solutions business and warned of the ongoing challenges in some of its end markets.

The company blamed the revenue decline on the continued destocking at selected spine customers within the Invibio business, which was first reported in the second half of last year. Revenue for the division in the six months ended March 31st fell to £24.2m compared to £25.5m for the same period last year.

In a statement Victrex said: "We are pleased to report that, despite continued global economic challenges, group sales volume for the first half of 1,392 tonnes was ahead of the same period for last year (1,377 tonnes).

"As expected, this reflects a stronger performance from our Victrex Polymer Solutions business (VPS) in the second quarter with group sales volume of 752 tonnes compared to the first quarter of 640 tonnes. The first half has also seen continued progress from speciality products, predominantly driven by success in our Aptiv films business.

"We have made further progress with regulatory approvals in the spine market in Asia and the initial response to the launch of our dental product line, JUVORATM, has been positive."

Looking ahead, the initial order book for April was described as 'robust', the capital investment programme is on track, and there are strong opportunities to drive growth into new markets, applications and geographies.

The share price dropped 2.95% to 1,548p by 08:40.

NR

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Will a second wave of Covid lead to another stockmarket crash?
Stockmarkets

Will a second wave of Covid lead to another stockmarket crash?

Can we expect to see another lockdown like in March, and what will that mean for your money? John Stepek explains.
18 Sep 2020
Here’s why you really should own at least some bitcoin
Bitcoin

Here’s why you really should own at least some bitcoin

While bitcoin is having a quiet year – at least in relative terms – its potential to become the default cash system for the internet is undiminished, …
16 Sep 2020
IAG's share price is ready for take-off - here's how to play it
Trading

IAG's share price is ready for take-off - here's how to play it

The owner of British Airways has had a turbulent year, but is now worth a punt. Matthew Partridge explains the best way to play it.
8 Sep 2020